Navigation Links
Codexis Names Jacques Beaudry-Losique VP Corporate Development & Strategy
Date:3/8/2011

REDWOOD CITY, Calif., March 8, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced that Jacques Beaudry-Losique has joined the company as Vice President, Corporate Development and Strategy.  Mr. Beaudry-Losique joins Codexis from the U.S. Department of Energy, and will be responsible for corporate strategic planning for Codexis' bioindustrials businesses and directing the company's government relations programs. He will report to Joseph Sarret, M.D., Chief Business Officer.

"Jacques Beaudry-Losique brings Codexis broad knowledge of the clean energy sector and senior leadership experience in managing renewable energy programs for the U.S. government, as well as a depth of experience working with Fortune 500 corporations," said Alan Shaw, Ph.D. President and Chief Executive Officer. "His extensive management and policy background will be vital to Codexis as we expand our business. We are very pleased to welcome him to our management team."

Mr. Beaudry-Losique has more than 20 years experience working in the energy and technology sectors.  Most recently, he held senior policy and management positions at the Department of Energy for six years, from 2005 to 2011. Previously, he worked with and advised Fortune 500 companies while at McKinsey & Co. and in strategic planning and management roles at General Electric and Shell.

While at DoE, he led efforts to build a second generation biofuels industry across two administrations, managed three major energy efficiency and renewable energy programs and served for two years as Deputy Assistant Secretary for Renewable Energy.  He was also instrumental in decisions to invest more than $1.5 billion of Recovery Act funds in renewable energy projects, including $800 million in biofuels projects – as well as the project selection, tracking and management of many of these programs.  

Prior to joining DoE, Mr. Beaudry-Losique held key engineering and management roles for leading global companies in energy and technology.  At GE Power Systems, he led technology acquisition programs in high growth sectors including biomass and fuel cells as business development leader.  He also held management positions at McKinsey & Co. and Aspen Technologies, a process engineering software company.  He began his career with Shell Canada where he held senior engineering, fuel quality and process optimization roles.

He holds a bachelor of science degree in chemical engineering from the University of Montreal, a master of science degree in engineering management from Stanford University and a master of science degree in management from MIT.

Codexis is a clean technology company. Codexis develops optimized biocatalysts that make industrial processes faster, cleaner and more efficient. Codexis' technology is commercialized with leading global pharmaceutical companies and in development for advanced biofuels with Shell and carbon capture. Other potential markets for the company's biocatalyst-enabled solutions include chemicals and water treatment. For more information, see www.codexis.com.

Forward-Looking Statements

This press release contains forward-looking statements relating to the potential expansion of our business.  You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control and that could materially affect actual results.  Factors that could materially affect actual results can be found in Codexis' Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 10, 2011, including under the caption "Risk Factors."  Codexis expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.

Contact: Media; Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212-827-3771.  Investors; Robert Lawson, robert.lawson@codexis.com, 650-421-8137


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Codexis Announces Carbon Capture Progress at ARPA-E Summit
2. Codexis Names David Anton CTO & SVP, Process Development & Manufacturing
3. Codexis to Present at the Jefferies and Pacific Crest Conferences
4. Codexis Signs First Japanese Biocatalysis Collaboration With Dainippon Sumitomo Pharma
5. Codexis to Announce Fourth Quarter 2010 Financial Results on February 3, 2011
6. Codexis to Present at Piper Conference
7. Codexis to Announce Third Quarter 2010 Financial Results October 28, 2010
8. Codexis Expands Codex® Panel Product Family at CPhI
9. Codexis to Present at the Pacific Crest Technology Leadership Forum
10. Codexis Names Peter Strumph SVP, Commercial Operations
11. Codexis CEO Alan Shaw Named Ernst & Young Entrepreneur Of The Year® 2010 Recipient in Northern California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , USA, March 29, 2017 Stryker announced ... Cares by People magazine, in partnership with Great Place ... companies on the list. This list highlights the top ... succeeded in business while also demonstrating respect, compassion and ... To determine the companies on the ...
(Date:3/29/2017)... 29, 2017 On March 28, the U.S. Food and ... with relapsing forms of multiple sclerosis (MS) and primary ... approved by the FDA for PPMS. Ocrevus is an ... "Multiple sclerosis can have a profound impact ... M.D., director of the Division of Neurology Products in ...
(Date:3/29/2017)... March 29, 2017 FinancialBuzz.com News Commentary  ... Data published in a research report by ... reach a value of USD 55.8 billion by 2025. The projection takes ... States and a more open approach towards cannabis products around ... Florida , North Dakota , ...
Breaking Medicine Technology:
(Date:3/29/2017)... Yorba Linda, Ca (PRWEB) , ... March 29, ... ... a standard process in many scientific laboratories. The assembly protocols involve many repetitive ... is well suited for automation, which enables the high-throughput needed, and results in ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of the University of Pennsylvania ... have made a $10 million gift to establish the Ken Moelis and Julie ... pathway to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests ...
(Date:3/28/2017)... ... March 28, 2017 , ... For many women, getting birth control isn’t as easy as ... they either don’t have access to a health care facility or a pharmacy within 60 ... of the United States or for many who are faced with health or personal issues ...
(Date:3/28/2017)... ... ... The Thyroid Secret is a specialized 9-part documentary series ... recently launched on March 1, and Dr. Wentz discussed varied benefits and aspects ... Wentz is a licensed pharmacist and a foremost thyroid specialist. After being diagnosed ...
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, the leading provider ... a free, public-facing tool for analyzing the costs of various drug regimens in ... information to patients, providers, insurers and pharmaceutical companies about the estimated costs of ...
Breaking Medicine News(10 mins):